WASHINGTON D.C. — In a dramatic public statement today, President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. announced that the U.S. Food and Drug Administration (FDA) will immediately notify physicians nationwide about recent evidence suggesting that using acetaminophen (often sold as Tylenol) during pregnancy may be linked with an increased risk of autism in children.
At the press conference, Trump was emphatic:
“Taking Tylenol is NOT GOOD. I’ll say it. IT’S NOT GOOD.”
Kennedy Jr. joined in urging caution. He said pregnant women should limit the use of acetaminophen unless it is absolutely necessary (for example, in the case of a high fever or serious pain), noting that in a small number of cases the risk appears higher when acetaminophen is used chronically throughout pregnancy.
The announcement includes plans for a safety label change for acetaminophen and a public‐service campaign aimed at informing both medical professionals and expectant mothers.
However, the move has sparked criticism from some in the scientific and medical communities. Experts point out that so far, the studies showing a connection are observational and show association—not proof of causation. Others warn that untreated fever in pregnancy also carries its own risks.
Source link
